Showing results (281-290 of 597) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Annals of the Rheumatic Diseases|June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR modelWanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Scientific Reports|September 5, 2023
Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatmentJérôme Avouac, Eloïse Vandebeuque, Alice Combier, et al.
Arthritis Research & Therapy|November 30, 2013
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesisMirko Manetti, Serena Guiducci, Eloisa Romano, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 15, 2024
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosisElizabeth R Volkmann, Christopher P Denton, Martin Kolb, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2006
Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B)Amélie Servettaz, Mathieu C Tamby, Philippe Guilpain, et al.
The Journal of Rheumatology|November 18, 2009
Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional studyOlivier Meyer, Luc De Chaisemartin, Pascale Nicaise-Roland, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2007
[Management of digital ulcers from systemic scleroderma]Camille Francès, Yannick Allanore, Jean Cabane, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Pageof 60